3051 companies

Australis Capital

Market Cap: US$25.4k

Operates as a cannabis company.

AUSA.F

US$0.0001

7D

0%

1Y

0%

Baseline Productions

Market Cap: US$4.1k

Does not have significant operations.

BSSP

US$0.000001

7D

0%

1Y

0%

U.S. Stem Cell

Market Cap: US$66.2k

A biotechnology company, engages in the discovery, development, and commercialization of autologous cellular therapies for the treatment of chronic and acute heart damage, and vascular and autoimmune diseases in the United States.

USRM

US$0.0001

7D

9,900.0%

1Y

n/a

Amarantus BioScience Holdings

Market Cap: US$630.0

A biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine.

AMBS

US$0.000001

7D

0%

1Y

n/a

CEN Biotech

Market Cap: US$65.0

Focuses on the manufacture, production, and development of light emitting diode lighting technology and hemp-based products.

CENB.F

US$0.000001

7D

0%

1Y

0%

co.don

Market Cap: €360.8k

Does not have significant operations.

CNW

€0.013

7D

35.0%

1Y

42.1%

NDT Pharmaceuticals

Market Cap: US$44.8k

A biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury.

NDTP

US$0.094

7D

54.1%

1Y

-66.2%

Isodiol International

Market Cap: US$128.0

Engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States.

ISOL.F

US$0.000001

7D

0%

1Y

0%

Pharmsynthez

Market Cap: ₽1.4b

Public Joint-Stock Company ‘Pharmsynthez’, a pharmaceutical company, researches, manufactures, and distributes officinal and generic active pharmaceutical ingredients in Russia and CIS countries.

LIFE

₽4.51

7D

0%

1Y

-23.5%

IMGTLtd

Market Cap: ₩57.4b

Engages in researching and developing of an ultrasound-guided therapy technology for genetic therapy and drug delivery systems.

A456570

₩11,200.00

7D

-1.1%

1Y

-12.5%

Hainan Shuangcheng Pharmaceuticals

Market Cap: CN¥3.2b

Hainan Shuangcheng Pharmaceuticals Co., Ltd.

002693

CN¥7.78

7D

-5.1%

1Y

49.0%

HEM Pharma

Market Cap: ₩135.8b

Operates as a microbiome healthcare company in South Korea and internationally.

A376270

₩19,210.00

7D

2.4%

1Y

n/a

Anti-Microbial Savior BioteQ

Market Cap: NT$2.8b

Focuses on the research and development of pharmaceutical products in Taiwan.

6864

NT$87.70

7D

3.2%

1Y

197.8%

Libra Infusions

Market Cap: ৳1.8b

Manufactures and sells injectable intravenous fluids in Bangladesh.

LIBRAINFU

৳815.00

7D

4.7%

1Y

15.9%

Africure Pharmaceuticals

Market Cap: US$57.1m

Manufactures and distributes pharmaceutical products.

AFRP.N0000

US$6.06

7D

0%

1Y

0%

Maven Brands

Market Cap: CA$702.8k

Together with its subsidiary, engages in the production, toll-processing, and packaging of medical cannabis in Canada.

MJ

CA$0.02

7D

0%

1Y

33.3%

Andros PharmaceuticalsLtd

Market Cap: NT$807.6m

A biopharmaceutical company, engages in developing novel drug delivery platform technologies.

6917

NT$17.80

7D

0.8%

1Y

-3.0%

Bharat Immunologicals & Biologicals

Market Cap: ₹930.1m

A biotechnology company, engages in the manufacture and sale of pharmaceutical products in India.

524663

₹21.54

7D

-4.8%

1Y

-27.0%

Proteina

Market Cap: ₩188.7b

Proteina Co.,Ltd. develops protein-protein interaction profiling technology.

A468530

₩17,500.00

7D

4.2%

1Y

n/a

CKD Bio

Market Cap: ₩125.6b

Engages in the manufacturing and sale of pharmaceutical products in South Korea, Europe, Asia, the Middle East, and internationally.

A063160

₩22,900.00

7D

1.8%

1Y

-34.5%

Aoxing Pharmaceutical Company

Market Cap: US$4.1m

A specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People’s Republic of China.

AOXG

US$0.011

7D

64.6%

1Y

72.6%

Yoda Pharmaceuticals

Market Cap: NT$4.0b

An AI-driven company, focuses on advancing drug research and development targeting central nervous system disorders.

7829

NT$50.20

7D

32.1%

1Y

n/a

Hwail PharmaceuticalLtd

Market Cap: ₩93.6b

Develops pharmaceutical raw materials in South Korea.

A061250

₩1,101.00

7D

-1.2%

1Y

-34.1%

Wakamoto PharmaceuticalLtd

Market Cap: JP¥10.7b

Manufactures and sells ethical and non-prescription drugs in Japan.

4512

JP¥308.00

7D

0%

1Y

23.2%

Protect Animal Health

Market Cap: NT$4.3b

Engages in the development of therapeutic vaccines for the animals.

7850

NT$43.65

7D

-1.6%

1Y

n/a

GeneMatrix

Market Cap: ₩48.9b

Develops diagnostic products for various diseases in the field of molecular diagnostics.

A109820

₩2,400.00

7D

-2.4%

1Y

-33.1%

Moogene Medi

Market Cap: ₩22.3b

Develops gene therapies based on its proprietary gene-editing platform technology.

A322970

₩2,215.00

7D

-1.3%

1Y

34.7%

BGM Group

Market Cap: US$1.4b

Through its subsidiaries, operates as a pharmaceutical and chemical company in China.

BGM

US$7.51

7D

-6.4%

1Y

n/a

Curachem

Market Cap: ₩12.3b

Provides services in custom carbon-14 radio labeling, stable isotope labeling, and medical chemistry and process development.

A456190

₩7,000.00

7D

0%

1Y

-58.3%

Dannex Ayrton Starwin

Market Cap: GH₵0

Manufactures and sells pharmaceutical products in Ghana.

DASPHARMA

GH₵0.38

7D

0%

1Y

0%

THC Biomed Intl

Market Cap: CA$3.3m

Produces and sells medical and recreational cannabis in Canada.

THC

CA$0.02

7D

0%

1Y

-50.0%

Pharmicell

Market Cap: ₩668.4b

A biopharmaceutical company, develops and sells stem cell drugs in South Korea and internationally.

A005690

₩11,140.00

7D

2.8%

1Y

90.4%

Epibiotech

Market Cap: ₩32.3b

A biopharmaceutical research company, develops cell and antibody treatments for hair restoration medical needs.

A446440

₩14,000.00

7D

4.6%

1Y

37.5%

ORIENT BIO

Market Cap: ₩70.1b

Operates in the bio-industry in South Korea.

A002630

₩591.00

7D

-7.9%

1Y

22.1%

K PharmaInc

Market Cap: JP¥7.8b

Engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan.

4896

JP¥671.00

7D

-3.5%

1Y

-13.5%

Anya Biopharm

Market Cap: NT$3.3b

A pharmaceutical company, develops platform for oral peptides.

7776

NT$67.40

7D

12.3%

1Y

n/a

Page 84 of 85